← Back to Clinical Trials
Recruiting NCT04832568

NCT04832568 Perioperative EEG-Monitoring and Postoperative Delirium in Patients Undergoing Cardiovascular Surgery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04832568
Status Recruiting
Phase —
Sponsor Huazhong University of Science and Technology
Condition Delirium
Study Type OBSERVATIONAL
Enrollment 200 participants
Start Date 2021-06-17
Primary Completion 2026-12

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 200 participants in total. It began in 2021-06-17 with a primary completion date of 2026-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Postoperative delirium is common in patients undergoing cardiovascular surgery and associated with poor outcomes. However the pathogenesis of postoperative delirium is poorly understood. Multichannel electroencephalogram is a recognized tool for identifying neurophysiologic states during anesthesia, sleep, and arousal. The aim of the current study is to evaluate the mechanisms and predictors of postoperative delirium in patients undergoing cardiovascular surgery using electroencephalogram.

Eligibility Criteria

Inclusion Criteria: 1. age of at least 18 years 2. normal cognitive function at the time of enrollment evidenced by a Mini-Mental State Examination (MMSE) score of more than 24 of 30 3. Chinese Mandarin as the native language 4. providing informed consent Exclusion Criteria: 1. pre-existing delirium assessed according to the Confusion Assessment Method (CAM) 2. history of neurological or psychiatric disease 3. impaired vision or auditory function which may effect the assessments 4. unwillingness to participate in the study

Contact & Investigator

Central Contact

Hua Zheng, Dr.

✉ hzheng@hust.edu.cn

📞 0086-27-83663173

Frequently Asked Questions

Who can join the NCT04832568 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Delirium. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04832568 currently recruiting?

Yes, NCT04832568 is actively recruiting participants. Contact the research team at hzheng@hust.edu.cn for enrollment information.

Where is the NCT04832568 trial being conducted?

This trial is being conducted at Wuhan, China.

Who is sponsoring the NCT04832568 clinical trial?

NCT04832568 is sponsored by Huazhong University of Science and Technology. The trial plans to enroll 200 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology